These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15316900)

  • 1. Young age and outcome for women with early-stage invasive breast carcinoma.
    Zhou P; Recht A
    Cancer; 2004 Sep; 101(6):1264-74. PubMed ID: 15316900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
    Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is mastectomy superior to breast-conserving treatment for young women?
    Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma.
    Kroman N; Holtveg H; Wohlfahrt J; Jensen MB; Mouridsen HT; Blichert-Toft M; Melbye M
    Cancer; 2004 Feb; 100(4):688-93. PubMed ID: 14770422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast-conserving therapy in young women with invasive carcinoma of the breast.
    Borg MF
    Australas Radiol; 2004 Sep; 48(3):376-82. PubMed ID: 15344990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
    Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
    Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting outcome for young women with early stage invasive breast cancer treated with breast-conserving therapy.
    Zhou P; Gautam S; Recht A
    Breast Cancer Res Treat; 2007 Jan; 101(1):51-7. PubMed ID: 16821084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma.
    van der Sangen MJ; van de Poll-Franse LV; Roumen RM; Rutten HJ; Coebergh JW; Vreugdenhil G; Voogd AC
    Eur J Surg Oncol; 2006 Feb; 32(1):34-8. PubMed ID: 16305821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuing risk of ipsilateral breast relapse after breast-conserving therapy at long-term follow-up.
    Kreike B; Hart AA; van de Velde T; Borger J; Peterse H; Rutgers E; Bartelink H; van de Vijver MJ
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1014-21. PubMed ID: 18234444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.
    Vo T; Xing Y; Meric-Bernstam F; Mirza N; Vlastos G; Symmans WF; Perkins GH; Buchholz TA; Babiera GV; Kuerer HM; Bedrosian I; Akins JS; Hunt KK
    Am J Surg; 2007 Oct; 194(4):527-31. PubMed ID: 17826073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors that influence surgical choices in women with breast carcinoma.
    Staradub VL; Hsieh YC; Clauson J; Langerman A; Rademaker AW; Morrow M
    Cancer; 2002 Sep; 95(6):1185-90. PubMed ID: 12216083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant increase in breast conservation in 16 years of trials conducted by the Austrian Breast & Colorectal Cancer Study Group.
    Jakesz R; Samonigg H; Gnant M; Kubista E; Depisch D; Kolb R; Mlineritsch B; Mischinger HJ; Menzel RC; Steindorfer P; Kwasny W; Tausch C; Stierer M; Taucher S; Seifert M; Hausmaninger H;
    Ann Surg; 2003 Apr; 237(4):556-64. PubMed ID: 12677153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes after breast conservation therapy for early stage breast cancer in a community setting.
    McCloskey SA; Botnick LE; Rose CM; Malcolm AW; Ozohan ML; Mena R; Llamas L; Tao ML
    Breast J; 2006; 12(2):138-44. PubMed ID: 16509838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.
    Robson M; Svahn T; McCormick B; Borgen P; Hudis CA; Norton L; Offit K
    Cancer; 2005 Jan; 103(1):44-51. PubMed ID: 15558796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.